|
|
||||||||
Lipids and Lipoproteins |
1
Department of Laboratory Medicine, Children's Hospital and Department of Pathology, Harvard Medical School, Boston, MA 02115.
2
Department of Medicine, Washington University, St.
Louis, MO 63110.
3
Department of Pathology and Laboratory Medicine,
University of Wisconsin, Madison, WI 53792-2472.
a Address correspondence to this author at: 600 Highland Avenue, Madison, WI 53792-2472. Fax 608-263-0910; e-mail da.wiebe{at}hosp.wisc.edu.
Direct assays for the determination of HDL-cholesterol (HDL-C) have recently become available. The methods are precise, require small sample volume, and appear to be less affected by increased triglycerides than traditional precipitation methods. In this study, we describe the inter- and intralaboratory variability of the Boehringer Mannheim Corporation direct HDL-C assay and its performance in external proficiency testing surveys. A comparison study among three laboratories, using different analyzers and 85 serum specimens, showed a correlation coefficient (r) of 0.99. The direct HDL-C assay also showed good agreement with the ultracentrifugation-dextran sulfate-Mg2+ method (r = 0.98) and the Cholesterol Reference Method Laboratory Network-Designated Comparison Method (a = 0.98x + 4.75 mg/L, r = 0.98). Total error at medical decision levels ranged from -0.8% to +11.1%. Furthermore, this assay performed adequately in the College of American Pathologists and the ALERT® surveys as well as the CDC Lipid Standardization Program and met all performance criteria of regulatory agencies.
The following articles in journals at HighWire Press have cited this article:
![]() |
T. Wu, W. C. Willett, N. Rifai, and E. B. Rimm Plasma Fluorescent Oxidation Products as Potential Markers of Oxidative Stress for Epidemiologic Studies Am. J. Epidemiol., September 1, 2007; 166(5): 552 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Peeters, A. W. van den Beld, H. Attalki, H. v. Toor, Y. B. de Rijke, G. G. J. M. Kuiper, S. W. J. Lamberts, J. A. M. J. L. Janssen, A. G. Uitterlinden, and T. J. Visser A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E75 - E81. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Warnick, M. Nauck, and N. Rifai Evolution of Methods for Measurement of HDL-Cholesterol: From Ultracentrifugation to Homogeneous Assays Clin. Chem., September 1, 2001; 47(9): 1579 - 1596. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Sampson, A. Aubry, G. Csako, and A. T. Remaley Triple Lipid Screening Test: A Homogeneous Sequential Assay for HDL-Cholesterol, Total Cholesterol, and Triglycerides Clin. Chem., March 1, 2001; 47(3): 532 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nauck, M. S. Graziani, D. Bruton, C. Cobbaert, T. G. Cole, F. Lefevre, W. Riesen, P. S. Bachorik, and N. Rifai Analytical and Clinical Performance of a Detergent-based Homogeneous LDL-Cholesterol Assay: A Multicenter Evaluation Clin. Chem., April 1, 2000; 46(4): 506 - 514. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Kimberly, E. T. Leary, T. G. Cole, and P. P. Waymack Selection, Validation, Standardization, and Performance of a Designated Comparison Method for HDL-Cholesterol for Use in the Cholesterol Reference Method Laboratory Network Clin. Chem., October 1, 1999; 45(10): 1803 - 1812. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |